Humanetics Corporation to Participate in Benchmark Healthcare Investor Conference This Week

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Humanetics Corporation announced today that executive management team members will participate in the Benchmark Company’s 5th Annual Healthcare House Call Virtual Investor Conference this week.

The conference takes place on Thursday, May 29th, and Humanetics will be featured during the 1:30 – 2:10 ET time slot.

About Humanetics Corporation

Humanetics is a clinical-stage pharmaceutical company engaged in the accelerated discovery, development, and commercialization of proprietary drugs in markets with urgent and unmet needs, with a focus on radiation modulators for oncology and medical countermeasures. For more information, visit www.humaneticscorp.com.

Humanetics to participate in benchmark investor conferrence.

Contacts

Ronald J. Zenk

Chief Executive Officer

Humanetics Corporation

952-400-0400

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.37
+0.22 (0.09%)
AAPL  329.71
-3.31 (-1.00%)
AMD  617.80
+6.04 (0.99%)
BAC  53.56
-0.87 (-1.59%)
GOOG  335.43
-5.31 (-1.56%)
META  726.71
+1.53 (0.21%)
MSFT  515.77
+2.88 (0.56%)
NVDA  231.97
+3.59 (1.57%)
ORCL  137.77
+0.47 (0.34%)
TSLA  357.19
+2.38 (0.67%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.